HIPP RAYMOND R 4
4 · NEOGENOMICS INC · Filed May 9, 2019
Insider Transaction Report
Form 4
HIPP RAYMOND R
Director
Transactions
- Sale
Common Stock
2019-05-07$22.61/sh−31,521$712,690→ 256,059 total - Sale
Common Stock
2019-05-08$22.36/sh−118,479$2,649,190→ 137,580 total
Holdings
- 6,667
Stock Option (Right to Buy)
Exercise: $7.27From: 2018-05-25Exp: 2022-05-25→ Common Stock (6,667 underlying) - 3,017
Stock Option (Right to Buy)
Exercise: $11.60From: 2019-06-01Exp: 2023-06-01→ Common Stock (3,017 underlying) - 2,777
Stock Option (Right to Buy)
Exercise: $9.11From: 2017-07-28Exp: 2021-07-28→ Common Stock (2,777 underlying)
Footnotes (2)
- [F1]On July 28, 2016, Mr. Hipp was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F2]On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.